Kelyniam Global, Inc. KLYG
Rating
Rating Factors
Company Overview
Kelyniam Global, Inc. (OTC: KLYG) is a publicly traded company associated with the medical technology and patient-specific implant industry. Based on available public disclosures and market references, the company’s primary activities have centered on the development and commercialization of customized cranial and craniofacial implants used in neurosurgical and reconstructive procedures. The company has been linked to healthcare manufacturing and medical device operations serving hospitals, surgeons, and specialized healthcare providers.
Publicly available information regarding the company’s current scale, revenue composition, and operating structure is limited and in some cases inconsistent across filings and market data platforms. Historical references indicate that Kelyniam’s business model focused on patient-specific implants manufactured using imaging and digital modeling technologies. Data regarding recent operating performance, active business segments, or current strategic positioning is inconclusive based on available public sources.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $0.07
- Current
- $0.12
- High
- $0.30
Valuation
Dividends and Shares
Corporate Info
Canton, CT 06019